The Mark Foundation for Cancer Research actively seeks to accelerate research that will transform the prevention, diagnosis, and treatment of cancer.
The ASPIRE Awards from The Mark Foundation for Cancer Research aim to support high-risk, high-reward projects in cancer research that may lack extensive preliminary data. The awards focus on accelerating understanding of cancer, therapeutic discovery, translational science, innovative technologies, and clinical research. They prioritize projects with the potential to impact cancer treatment and understanding significantly, and offer two levels of funding based on the project's duration and scope. Projects can start with an ASPIRE I Award for short-term feasibility studies, with the possibility of advancing to ASPIRE II for more extended, in-depth research.